Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Cabrelle

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Blood|March 22, 2013
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemiaAntonella Teramo, Cristina Gattazzo, Francesca Passeri, et al.
British Journal of Haematology|March 11, 2014
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazoleFederica Frezzato, Valentina Trimarco, Veronica Martini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glandsPaolo Sfriso, Francesca Oliviero, Fiorella Calabrese, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Oncotarget|January 19, 2017
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathwaysSabrina Manni, Marilena Carrino, Martina Manzoni, et al.
Stem Cell Reviews and Reports|December 2, 2010
In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cellsSveva Bollini, Michela Pozzobon, Muriel Nobles, et al.
Immunologic Research|January 4, 2014
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritisUgo Fiocco, Benedetta Accordi, Veronica Martini, et al.
Plos One|May 5, 2011
ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosisElisabetta Zulato, Francesca Favaretto, Caterina Veronese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein responseSabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|May 11, 2006
Multiple myeloma cell survival relies on high activity of protein kinase CK2Francesco A Piazza, Maria Ruzzene, Carmela Gurrieri, et al.
Blood|March 22, 2013
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemiaAntonella Teramo, Cristina Gattazzo, Francesca Passeri, et al.
British Journal of Haematology|March 11, 2014
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazoleFederica Frezzato, Valentina Trimarco, Veronica Martini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glandsPaolo Sfriso, Francesca Oliviero, Fiorella Calabrese, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Oncotarget|January 19, 2017
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathwaysSabrina Manni, Marilena Carrino, Martina Manzoni, et al.
Stem Cell Reviews and Reports|December 2, 2010
In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cellsSveva Bollini, Michela Pozzobon, Muriel Nobles, et al.
Immunologic Research|January 4, 2014
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritisUgo Fiocco, Benedetta Accordi, Veronica Martini, et al.
Plos One|May 5, 2011
ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosisElisabetta Zulato, Francesca Favaretto, Caterina Veronese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein responseSabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, et al.
Pageof 5